Liver retransplantation for hepatitis C virus recurrence: A survey of liver transplant programs in the United States

Clinical Gastroenterology and Hepatology

Volumn 3, Issue 7, 2005, Pages 700-704

  Burton Jr , James R ^a,b   Rosen, Hugo R ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN;

ADMINISTRATIVE PERSONNEL; ARTICLE; CLINICAL PROTOCOL; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; GRAFT FAILURE; HEALTH PROGRAM; HEALTH SURVEY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER CIRRHOSIS; LIVER DISEASE; LIVER GRAFT; LIVER TRANSPLANTATION; QUESTIONNAIRE; RECURRENT DISEASE; REOPERATION; SURVIVAL TIME; UNITED STATES;

HEALTH CARE SURVEYS; HEPATITIS C; HUMANS; LIVER TRANSPLANTATION; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PROGNOSIS; RECURRENCE; REOPERATION; TREATMENT FAILURE; UNITED STATES;

EID: 22144475765     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1542-3565(05)00158-8     Document Type: Article

References (28)

1. E. Gane The natural history and outcome of liver transplantation in hepatitis C virus-infected recipients Liver Transpl 9 2003 S28 S34
2. G. Fattovich, G. Giustina, F. Degos Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C J Hepatol 27 1997 201 205
3. Irish Hepatology Research Group E. Kenny-Walsh Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin N Engl J Med 340 1999 1228 1233
4. M. Berenguer, M. Prieto, J.M. Rayon Natural history of clinically compensated HCV-related graft cirrhosis following liver transplantation Hepatology 32 2000 852 858
5. S.W. Biggins, A. Beldecos, J.M. Rabkin Retransplantation for hepatic allograft failure prognostic modeling and ethical considerations Liver Transpl 8 2002 313 322
6. H.R. Rosen, P. Martin Hepatitis C infection in patients undergoing liver retransplantation Transplantation 66 1998 1612 1616
7. H.Y. Yoo, A. Maheshwari, P.J. Thuluvath Retransplantation of liver primary graft nonfunction and hepatitis C virus are associatied with worse outcome Liver Transpl 9 2003 897 904
8. J.F. Markmann, J.S. Markowitz, H. Yersiz Long-term survival after retransplantation of the liver Ann Surg 226 1997 408 418
9. D. Azoulay, M.M. Linhares, E. Huguet Decision for retransplantation of the liver an experience- and cost-based analysis Ann Surg 236 2002 713 721
10. T. Wong, J. Devlin, N. Rolando Clinical characteristics affecting the outcome of liver retransplantation Transplantation 64 1997 878 882
11. H.R. Rosen, J.P. Madden, P. Martin A model to predict survival following liver retransplantation Hepatology 29 1999 365 370
12. W.R. Kim, R.H. Wiesner, J.J. Poterucha Hepatic retransplantation in cholestatic liver disease impact of the interval to retransplantation on survival and resource utilization Hepatology 30 1999 395 400
13. H.R. Doyle, F. Morelli, J. McMichael Hepatic retransplantation an analysis of risk factors associated with outcome Transplantation 61 1996 1499 1505
14. M. Facciuto, D. Heidt, J. Guarrera Retransplantation for late liver graft failure predictors of mortality Liver Transpl 6 2000 174 179
15. H.R. Rosen, M. Prieto, T. Casanovas-Taltavull Validation and refinement of a survival model for liver retransplantation Hepatology 38 2003 460 469
16. R.M. Ghobrial, S. Saab, C. Lassman Donor and recipient outcomes in right lobe adult living donor liver transplantation Liver Transpl 8 2002 901 909
17. J.F. Markmann, J. Gornbein, J.S. Markowitz A simple model to estimate survival after retransplantation of the liver Transplantation 67 1999 422 430
18. F.Y. Yao, S. Saab, N.M. Bass Prediction of survival after liver retransplantation for late graft failure based on preoperative prognostic scores Hepatology 39 2004 230 238
19. K.D.S. Watt, E.R. Lyden, T.M. McCashland Poor survival after liver transplantation is hepatitis C to blame? Liver Transpl 9 2003 1019 1024
20. H. Rosen Retransplantation for hepatitis C implications of different policies Liver Transpl 6S 2000 S41 S46
21. Available at: www.unos.org. Accessed November 3, 2003.
22. G.R. Normal, D.L. Streiner Biostatistics The bare essentials 2000 BC Decker Inc Hamilton, Ontario, Canada 27 32
23. V. Mazzafero, A. Tagger, M. Schiavo Prevention of recurrent hepatitis C after liver transplantation with early interferon and ribavirin treatment Transpl Proc 33 2001 1355 1357
24. P. Sheiner, P. Boros, F. Klion The efficacy of prophylactic interferon alfa-2b in preventing recurrent hepatitis C after liver transplantation Hepatology 28 1998 831 838
25. N. Singh, T. Gayowski, C.F. Wannstedt Interferon-alpha for prophylaxis of recurrent viral hepatitis C in liver transplant recipients a prospective randomized, controlled trial Transplantation 65 1998 82 86
26. C. Manzarbeitia, L. Tepermann, N. Chalasani 40kDa pepinterferon as prophylaxis against HCV recurrence after liver transplantation preliminary results of a randomized, multicenter trial (abstract) Hepatology 34 2001 406A
27. S. Roayaie, T.D. Schiano, S.N. Thung Results of retransplantation for recurrent hepatitis C Hepatology 38 2003 1428 1436
28. J.R. Burton, S. Sonnenberg, H.R. Rosen Retransplantation for recurrent HCV in the MELD Era maximizing utility Liver Transpl 10 Suppl 2 2004 S59 S64